Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · Real-Time Price · USD

1.240

-0.060 (-4.62%)

At close: Nov 13, 2026, 4:00 PM EST

1.220

-0.020 (-1.61%)

After-hours: Nov 13, 2026, 6:23 PM EST

Alzamend Neuro Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Cash & Equivalents	7.59	0.71	3.95	0.38	5.14	14.06
Cash & Short-Term Investments	7.59	0.71	3.95	0.38	5.14	14.06
Cash Growth	35.06%	-82.00%	950.04%	-92.69%	-63.45%	628.97%
Prepaid Expenses	0.66	1.05	0.23	0.08	0.69	0.35
Total Current Assets	8.25	1.76	4.18	0.46	5.84	14.41
Property, Plant & Equipment	0.29	0.31	0.43	0.18	0.08	0.1
Total Assets	8.54	2.08	4.6	0.63	5.92	14.52

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Accounts Payable	2.74	1.35	0.63	2.93	2.87	1.16
Short-Term Debt	-	-	-	0.3	-	-
Other Current Liabilities	-	-	-	-	-	0
Total Current Liabilities	2.74	1.35	0.63	3.23	2.87	1.16
Total Liabilities	2.74	1.35	0.63	3.23	2.87	1.16

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	76.14	68.04	62.5	51.43	62	57.42
Retained Earnings	-70.33	-67.31	-58.54	-54.02	-44.07	-29.19
Comprehensive Income & Other	0	-	-	-	-14.88	-14.88
Total Common Equity	5.8	0.73	3.97	-2.59	3.05	13.35
Shareholders' Equity	5.8	0.73	3.97	-2.59	3.05	13.35
Total Liabilities & Equity	8.54	2.08	4.6	0.63	5.92	14.52

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Total Debt	-	-	-	0.3	-	-
Net Cash (Debt)	7.59	0.71	3.95	0.08	5.14	14.06
Net Cash Growth	35.06%	-82.00%	5141.53%	-98.53%	-63.45%	782.32%
Net Cash Per Share	1.93	0.21	8.76	1.00	71.17	213.10
Filing Date Shares Outstanding	4.83	4.79	2.9	0.09	0.07	0.07
Total Common Shares Outstanding	4.83	4.26	0.78	0.08	0.07	0.07
Working Capital	5.52	0.42	3.54	-2.77	2.97	13.25
Book Value Per Share	1.20	0.17	5.10	-33.94	42.41	188.78
Tangible Book Value	5.8	0.73	3.97	-2.59	3.05	13.35
Tangible Book Value Per Share	1.20	0.17	5.10	-33.94	42.41	188.78

SEC Filings: 10-K · 10-Q